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Abstract. Infections caused by Human Cytomegalovirus 
(HCMV) are very common in patients who undergo 
immunosuppression or immunocompromisation. The 
techniques used for routine HCMV detection are time-
consuming and lack specificity and sensitivity. The ability of 
the Polymerase Chain Reaction (PCR) to amplify HCMV 
DNA from clinical samples of the patients is a valuable 
diagnostic tool for the detection of HCMV in the early stages 
of the infection. We used a pair of primers to amplify a 435 
bp region of the immediate early-1 gene, to detect HCMV 
DNA in clinical samples from patients at high risk for 
HCMV infection. We found HCMV in the following type of 
patients: 6 out of 20 in immunosuppressed, 11 out of 31 in 
immunocompromised, 5 out of 8 in pregnant women, 4 out 
of 25 in patients with high anti-CMV IgM and IgG titres, 1 
out of 2 in patients with kidney failure, and 6 out of 14 in 
patients with opthalmic disorders. Sixty-seven specimens, 
which were found to be negative for CMV by the PCR 
technique, were used to inoculate human fibroblast 
monolayer cultures and PCR was performed to the DNA 
extracted from the cultured cells. Only in 1 out of the 67 
cases HCMV DNA was detected. 
Introduction 
HCMV is a viral pathogen of major importance belonging to 
the family of Herpesviridae. The primary disease is rare but 
infections caused by HCMV are common. HCMV is 
associated with silent infections which can be activated in 
immunosuppressed and immunodeficient patients, pregnant 
women and lowbirthweight neonates (1). 
Most current techniques for HCMV detection are based 
on serology such as latex agglutination and enzyme-linked 
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immunosorbent assay (ELISA). Active HCMV infection can 
be determined by cell culture, testing for cytopathic effect 
(CPE). However, both approaches have significant 
disadvantages. The tissue culture procedures are time-
consuming and expensive while the detection of anti-CMV 
antibodies in immunosuppressed and immunodeficient 
patients require high level of expertise (2). 
PCR is a rapid and sensitive method which has many 
diagnostic applications in medical practice (3,4). The use of 
PCR for the detection of HCMV viral DNA in clinical 
specimens (e.g. blood, urine, bronchoalveolar lavage) has 
been reported by many workers (5,6). 
We used PCR to amplify a 435 bp long sequence from the 
immediate early-1 gene of HCMV in blood samples from 
immunosuppressed and immunodeficient patients, pregnant 
women, patients with retinitis, and keratitis, and patients with 
high anti-CMV IgM and IgG titres. 
To increase the sensitivity of the method we combined 
our preliminary results from PCR with those obtained from 
cell culture of the initial samples and PCR amplification of 
the DNA extracted from the culture. 
Materials and methods 
DNA extraction 
Blood. Leucocytes were isolated from 3 ml blood using 
Lymphoprep (Nycomed AS) and lysed with the addition of 
400 μΐ TES buffer containing 100 μg/ml Proteinase K. After 
incubation at 37°C O/N samples were extracted once with 
phenol and once with phenol/chloroform. DNA was 
precipitated with the addition of 20 μΐ 5 M NaCl and 1 ml 
ethanol. DNA was recovered by centrifugation at 11,000 rpm 
for 15 min at 4°C, washed once with 70% ethanol and 
resuspended in 100 μΐ of double-distilled water. 
Cultured cells. Cells were trypsinized and collected by 
centrifugation at 1,600 rpm for 5 min. Pellets were then lysed 
with 2 ml lysis buffer (10 mM EDTA, 10 mM Tris-HCl pH 
7.8, 150 mM NaCl and 0.5% SDS) containing 100 μg/ml 
Proteinase Κ and incubated at 60°C for 60 min. Equal 
quantity of Proteinase Κ was added followed by incubation at 
60°C for another 60 min. Samples were extracted once with 
phenol and once with phenol/chloroform. DNA was 
precipitated with the addition of 100 μΐ 5 M NaCl and 5 ml 
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HCMV genome 
TRL IR L 1RS TRS 
5' . . CCAAGCGGCCTCTGATAACCAAGCC CCAGAGGAAGAGGAGGATGGTGCTG. . 3' 
5' CCAAGCGGCCTCTGATAACCAAGCC 3' 3'GGTCTCCTTCTCCTCCTACCACGAC 5' 
MIEI (IE1 731-755) PRIMERS MIE5 (IE1 1140-1165) 
PCR amplification 
• 
5'CCAAGCGGCCTCTGATAACCAAGCC GGTCTCCTTCTCCTCCTACCACGAC 3' 
PCR product (435bp) 
Figure 1. HCMV genome and related primers. 
Table I. Summary of results on the detection of HCMV by 
PCR. 
Study cases 
1. AIDS patients 
2. Patients with lymphoma 
3. Patients with malignancies 
4. Kidney transplant patients 
5. Heart transplant patients 
6. Pregnant women 
7. Patients with high anti-
CMV IgM and IgG titres 
8. Patients with kidney failure 



























a2 blood and aqueous humour; 4 blood. 
ethanol. DNA was recovered by centrifugation at 11,000 rpm 
for 15 min at 4°C and resuspended in 40 μΐ of double-
distilled water. 
Aqueous humour. NaOH was added to final concentration 
0.1 Ν and samples were boiled for 5 min. Samples were 
extracted once with phenol and once with phenol/chloroform. 
DNA was precipitated as described above. 
Cell culture. MRC-5 human embryonic lung fibroblasts were 
maintained in DMEM/F12 (Gibco BRL) containing 10% 
fetal calf serum and antibiotics (7). 
Subconfluent cell monolayers were infected with 10% of 
the initially isolated leucocytes and incubated at 37°C with 
5% C0 2 for 48 hours. 
Oligonucleotides and PCR amplification. We used a pair of 
primers, termed MIE-4 and MIE-5, which have been 
previously described (8,9) to amplify a 435 bp long sequence 
from the immediate early-1 gene of HCMV. The primers 
along with the HCMV IE-1 sequence are schematically 
presented in Fig. 1. 
500 ng DNA of each sample was amplified in a volume 
of 100 μΐ containing 200 μπι of dNTPs, 50 pmoles of each 
primer, 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 2 mM 
MgCl 2 and 2.5 units Taq polymerase (Gibco BRL). 
Amplification was performed in a thermal cycler (Perkin 
Elmer Cetus) using the following conditions: denaturation at 
94°C for 50 sec, annealing at 62°C for 30 sec and extension 
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Figure 2. Detection of HCMV DNA by PCR. Amplification products were electrophoresed through a 2% agarose gel. Lane 1 : negative control, lanes 2, 3, 4. 
5, 6, 8: positive samples, lanes 7, 9, 10, 11: negative samples, lane 15: negative control from CMV cell culture, lane 14: positive sample from CMV cell 
culture, lanes 12, 13: negative samples from CMV cell culture, lane 16: pUC18/HaeIIl molecular marker. 
at 72°C for 50 sec, increasing the extension time by 1 sec per 
cycle. Samples were subjected to 40 cycles of amplification. 
Twenty μΐ of the amplification products was analysed on 
a 2% agarose gel and visualized under UV illumination after 
staining with ethidium bromide. 
Results 
We examined 100 patients at high risk for CMV infection. 
Our results are summarised in Table I. HCMV DNA was 
detected in 33 out of the 100 examined patients. The 
presence of HCMV was judged from the amplification of a 
435 bp long sequence (Fig. 2). HCMV DNA was detected in 
5 out of 10 AIDS patients, 5 out of 11 patients with 
lymphomas (Hodgkin's and non-Hodgkin's), 1 out of 10 
patients with malignancies (e.g leucemia, myelodysplastic 
syndrome), 3 out of 10 kidney transplant patients, 5 out of 8 
pregnant women, 4 out of 25 patients with high anti-CMV 
IgM and IgG titres, 1 out of 2 patients with kidney failure, 6 
out of 14 patients with retinitis, and keratitis. Sixty-seven 
patients who were found to be CMV negative by the PCR 
were further examined with cell culture of the initial sample 
and application of the PCR in the DNA extracted from the 
culture. Only one of the examined samples was found 
positive after cell culture. This patient suffered from retinal 
necrosis and was found to be CMV positive by the PCR in 
the aqueous humour but negative in the blood. However, 
CMV was detected in his blood after cell culture and PCR 
amplification of the extracted DNA. 
Discussion 
CMV detection using traditional methods is hampered by 
low sensitivity and the long lag time between testing and 
obtaining a positive result. With the increase in the number 
of immunodeficient and immunocompromised patients being 
treated, CMV has become an important cause of morbidity 
and mortality in these patients and proper treatment requires 
prompt and accurate diagnosis. A rapid and sensitive method 
of viral DNA detection would be useful in identifying blood 
products and organs capable of transmitting infection, 
thereby increasing prevention (10). PCR has been proved to 
be sensitive and rapid as well as accurate and specific for the 
detection of small amounts of viral genomes (11,12). PCR 
does not depend on the immune response of the patient 
which can be defective due to postoperative pharmaceutical 
immunosuppression or due to immune disorders. Comparison 
of our preliminary negative results with the results obtained 
after PCR DNA amplification of the cell culture shows that 
PCR is a very accurate and sensitive method for the detection 
of HCMV in clinical specimens. Moreover, PCR does not 
have the drawbacks of previous methods and its application 
as a routine diagnostic tool in clinical virology is of major 
importance. The sensitivity and the accuracy of PCR in the 
detection of active infections makes this technique a 
powerful tool in diagnostic virology and is expected to 
reduce the morbidity and mortality rate in susceptible 
patients with higher risk for HCMV infection (e.g. multiple 
transfused, transplant patients, and immunodeficient 
patients). 
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